Cuvitru Alternatives Compared
| Cuvitru | Hizentra | Gammagard Liquid |
|
|---|
| Cuvitru (immune globulin subcutaneous) | Hizentra (immune globulin subcutaneous) | Gammagard Liquid (immune globulin intravenous and subcutaneous) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Primary Immunodeficiency Syndrome. Cuvitru may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Immunodeficiency Syndrome, Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Hizentra may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome, Multifocal Motor Neuropathy. Gammagard Liquid may also be used for purposes not listed in... View more |
Related suggestions Primary Immunodeficiency Syndrome
|
|||||||||||||||||||||||
| More about Cuvitru (immune globulin subcutaneous) | More about Hizentra (immune globulin subcutaneous) | More about Gammagard Liquid (immune globulin intravenous and subcutaneous) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Cuvitru has an average rating of 8.9 out of 10 from a total of 13 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 0% reported a negative effect. |
Hizentra has an average rating of 6.2 out of 10 from a total of 26 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 35% reported a negative effect. |
Gammagard Liquid has an average rating of 7.2 out of 10 from a total of 6 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: Cuvitru side effects in more detail. |
See also: Hizentra side effects in more detail. |
See also: Gammagard Liquid side effects in more detail. |
||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Cuvitru prices |
View all Hizentra prices |
View all Gammagard Liquid prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other immune globulin subcutaneous brands include: Cutaquig, Hizentra, Xembify | Other immune globulin subcutaneous brands include: Cutaquig, Cuvitru, Xembify | Other immune globulin intravenous and subcutaneous brands include: Gammaked, Gamunex-C | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
564 hours |
564 hours |
857.76 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 22 drugs are known to interact with Cuvitru:
|
A total of 22 drugs are known to interact with Hizentra:
|
A total of 104 drugs are known to interact with Gammagard Liquid:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.